Reference

1. Anonymous. Indian Pharmacopoeia. Published by the Controller of Publication, Govt. of India, Ministry of Health and Family Welfare, New Delhi, I and II, 2007, 179-183, 662-663. 
2. Anonymous. United State Pharmacopoeia. The United States Pharmacopoeial convention Inc, Rockville, MD, USA, 2007; 1988-1989.
3. Anonymous. http://www.wikipedia.com/Sitagliptin Phosphate.
4. Aulton M. Pharmaceutics: The Science of Dosage Form Design, International Student Edition, Newyork, 2007, 168-179, 304-321, 347-668.
5. Banker G and Rhodes C. Drug and Pharmaceutical Sciences, Modern Pharmaceutics, 3rd edition, 72: 333-394.
6. Bhalala chirag, Chauhan Sachin, Balaraman R, Seth A. K., Shah Chainesh, Dhamat Khushal and Hitesh Gevariya. Formulation and evaluation of sustained release bilayer tablets of Metformin HCl and Pioglitazone HCl, World Journal of Pharmaceutical research, 2012; 1(2): 242 257.
7. Bentley’s. Text book of Pharmaceutics, 8th edition, pg.no.140.
8. Bogner RH. Bioavailability and Bioequivalence of extended release oral dosage forms, US pharmacist, 1997; 22: 3-12.
9. Brahmankar D.M. and Jaiswal S.B. Biopharmaceutics and pharmacokinetics: A Tretise, 1 st edition, Vallabh prakashan, New delhi, 2006; 335-337.
10. Chien YW. Novel drug delivery system, Informa healthcare, 2nd edition revised and expanded, 2010; 50: 139-140.
11. Chinam Niranjan Patra, Arethi Bharani Kumar, Hemant Kumar Pandit, Satya Prakash Singh and Meduri Vimala devi. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride, Acta Pharm, 2007; 479–489.
12. Sharmin Rahman, Md. Abdullah Al Masum, FloridaSharmin, S. M. Ashraful Islam and Md. Selim Reza. Formulation and Evaluation of Bi-ayered SustainedRelease Matrix Tabletsof Tramadol Hydrochloride, Journal of Applied Pharmaceutical Science, 2(6), 129-134,2012.
13. Shidhaye SS, Saindane NS, Sutar S and Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate, AAPS Pharma Sci Tech,9(3), 909-916, 2008.
14. Sinko P. J. Martin’s physicalpharmacy and pharmaceutical sciences, 5th edition,Lippincott Williams & Wilkins, New York, 523-558, 2008.
15. S. Jayaprakash, S. Mohamed Halith, K.Kulathuran Pillai, Priya Balasubramaniyam, P. U. Mohamed Firthouse and M. Boopathi.Formulation and evaluation of bilayer tabletsof amlodipine besilateand metprolol succinate S. Der Pharmacia Lettre, 3 (4), 143-154,2011.
16. Sonara GS, Jain DK and More DM. Preparation and in vitro evaluation of bilayer and floating bioadhesive tablets of rosiglitazone maleate, Asian J. Pharma. Sci, 2(4), 161-169. 2007.
17. Stephen D. Silberstein. Trends in Pharmacological Sciences, 27(8), 410-415,2006.
18. Sweetman SC (Eds), Martindale. The complete drug reference, 33rd edition, Great Britain, Pharmaceutical press, 456-458, 2002.
19. Turner S, Federici C, Hite M and Fassihi R. Formulation development and human in vitro- in vivo correlation for a novel,monolithic controlled releasematrix system of high load and highly water-soluble drug niacin, Drug Development and Industrial Pharmacy,30, 797-807, 2004.
20. Vogeleer J. Bilayer tablets – why special technology required, The courtoy R292F tabletpress, designed for qualitybilayer tablets, 1(1), 1-6, 2002.
21. Yellanki SK, Bigala R, Jawad ali syed, Deb SK and GorantiS. Design and in vitro evaluation of mucoadhesive minitablets for nasal drug delivery of sumatriptan succuinate, Asian J Pharma Clin Res, 3(3), 218-220, 2010.
22. Yie WC. Noveldrug delivery systems,2edition, Madison Avenue(NY), Marcel Dekker,Inc, 1992. 
23. https://go.drugbank.com/salts/DBSALT002821
24. https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin-phosphate
25. http://www.chemspider.com/Chemical-Structure.26466580.html